OLPX vs. NUS, HELE, NTCOY, IPAR, ODD, EPC, WALD, YSG, SHOT, and UG
Should you be buying Olaplex stock or one of its competitors? The main competitors of Olaplex include Nu Skin Enterprises (NUS), Helen of Troy (HELE), Natura &Co (NTCOY), Inter Parfums (IPAR), Oddity Tech (ODD), Edgewell Personal Care (EPC), Waldencast (WALD), Yatsen (YSG), Safety Shot (SHOT), and United-Guardian (UG).
Nu Skin Enterprises (NYSE:NUS) and Olaplex (NASDAQ:OLPX) are both small-cap consumer staples companies, but which is the better investment? We will compare the two companies based on the strength of their institutional ownership, profitability, community ranking, valuation, analyst recommendations, dividends, media sentiment, earnings and risk.
Olaplex has lower revenue, but higher earnings than Nu Skin Enterprises. Nu Skin Enterprises is trading at a lower price-to-earnings ratio than Olaplex, indicating that it is currently the more affordable of the two stocks.
Olaplex has a net margin of 10.91% compared to Olaplex's net margin of -0.17%. Nu Skin Enterprises' return on equity of 11.61% beat Olaplex's return on equity.
Nu Skin Enterprises has a beta of 1.16, meaning that its share price is 16% more volatile than the S&P 500. Comparatively, Olaplex has a beta of 2.45, meaning that its share price is 145% more volatile than the S&P 500.
In the previous week, Nu Skin Enterprises had 1 more articles in the media than Olaplex. MarketBeat recorded 3 mentions for Nu Skin Enterprises and 2 mentions for Olaplex. Olaplex's average media sentiment score of 1.47 beat Nu Skin Enterprises' score of 0.00 indicating that Nu Skin Enterprises is being referred to more favorably in the media.
Nu Skin Enterprises presently has a consensus target price of $20.83, suggesting a potential upside of 57.35%. Olaplex has a consensus target price of $2.51, suggesting a potential upside of 43.57%. Given Olaplex's higher possible upside, equities analysts clearly believe Nu Skin Enterprises is more favorable than Olaplex.
Nu Skin Enterprises received 481 more outperform votes than Olaplex when rated by MarketBeat users. Likewise, 64.23% of users gave Nu Skin Enterprises an outperform vote while only 34.12% of users gave Olaplex an outperform vote.
82.8% of Nu Skin Enterprises shares are owned by institutional investors. Comparatively, 87.4% of Olaplex shares are owned by institutional investors. 1.7% of Nu Skin Enterprises shares are owned by company insiders. Comparatively, 4.2% of Olaplex shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.
Summary
Olaplex beats Nu Skin Enterprises on 12 of the 18 factors compared between the two stocks.
Get Olaplex News Delivered to You Automatically
Sign up to receive the latest news and ratings for OLPX and its competitors with MarketBeat's FREE daily newsletter.
This chart shows the number of new MarketBeat users adding OLPX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Related Companies and Tools
